Loss of tau elicits axonal degeneration in a mouse model of Alzheimer's disease

[1]  L. Mucke,et al.  Epilepsy and cognitive impairments in Alzheimer disease. , 2009, Archives of neurology.

[2]  L. Goldstein,et al.  Amyloid precursor protein-induced axonopathies are independent of amyloid-beta peptides. , 2008, Human molecular genetics.

[3]  Seth Love,et al.  Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial , 2008, The Lancet.

[4]  J. Baron,et al.  Relationships between Hippocampal Atrophy, White Matter Disruption, and Gray Matter Hypometabolism in Alzheimer's Disease , 2008, The Journal of Neuroscience.

[5]  Oliver Wirths,et al.  Deficits in working memory and motor performance in the APP/PS1ki mouse model for Alzheimer's disease , 2008, Neurobiology of Aging.

[6]  S. Gross,et al.  Tuning Microtubule‐Based Transport Through Filamentous MAPs: The Problem of Dynein , 2008, Traffic.

[7]  Ram Dixit,et al.  Differential Regulation of Dynein and Kinesin Motor Proteins by Tau , 2008, Science.

[8]  M. Vitek,et al.  The Tau N279K Exon 10 Splicing Mutation Recapitulates Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17 Tauopathy in a Mouse Model , 2007, The Journal of Neuroscience.

[9]  Kim N. Green,et al.  Intracellular amyloid-β in Alzheimer's disease , 2007, Nature Reviews Neuroscience.

[10]  L. Mucke,et al.  Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model , 2007, Science.

[11]  B. C. Carter,et al.  Multiple-motor based transport and its regulation by Tau , 2007, Proceedings of the National Academy of Sciences.

[12]  Yaakov Stern,et al.  Incidence and Predictors of Seizures in Patients with Alzheimer's Disease , 2006, Epilepsia.

[13]  Jacek Szczygielski,et al.  Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer’s disease , 2006, Acta Neuropathologica.

[14]  Judianne Davis,et al.  Reducing Cerebral Microvascular Amyloid-β Protein Deposition Diminishes Regional Neuroinflammation in Vasculotropic Mutant Amyloid Precursor Protein Transgenic Mice , 2005, The Journal of Neuroscience.

[15]  Kefei Chen,et al.  Behavioral phenotypes of amyloid‐based genetically modified mouse models of Alzheimer's disease , 2005, Genes, brain, and behavior.

[16]  M. Vitek,et al.  A novel therapeutic derived from apolipoprotein E reduces brain inflammation and improves outcome after closed head injury , 2005, Experimental Neurology.

[17]  E. Masliah,et al.  Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer's Disease , 2005, Science.

[18]  T. Bayer,et al.  A modified β‐amyloid hypothesis: intraneuronal accumulation of the β‐amyloid peptide – the first step of a fatal cascade , 2004, Journal of neurochemistry.

[19]  John Q Trojanowski,et al.  Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs , 2004, Nature Medicine.

[20]  C. Broeckhoven,et al.  The role of tau (MAPT) in frontotemporal dementia and related tauopathies , 2004, Human mutation.

[21]  H. Mori,et al.  The distributions of tau short and long isoforms fused with EGFP in cultured cells. , 2004, Osaka city medical journal.

[22]  E. Mandelkow,et al.  Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses , 2003, Neurobiology of Aging.

[23]  D. Holtzman,et al.  Use of YFP to study amyloid-β associated neurite alterations in live brain slices , 2003, Neurobiology of Aging.

[24]  N. Quinn,et al.  Tau exon 10 +16 mutation FTDP-17 presenting clinically as sporadic young onset PSP , 2003, Neurology.

[25]  Masanori Kato,et al.  4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy , 2003, Acta Neuropathologica.

[26]  J. Sanes,et al.  PDAPP; YFP double transgenic mice: A tool to study amyloid‐β associated changes in axonal, dendritic, and synaptic structures , 2003, The Journal of comparative neurology.

[27]  W. Kamphorst,et al.  Impaired axonal transport of cortical neurons in Alzheimer’s disease is associated with neuropathological changes , 2002, Brain Research.

[28]  John T. Finn,et al.  Axonal Self-Destruction and Neurodegeneration , 2002, Science.

[29]  M. Vitek,et al.  Tau is essential to β-amyloid-induced neurotoxicity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[30]  E. Mandelkow,et al.  Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress , 2002, The Journal of cell biology.

[31]  H. Benveniste,et al.  Apolipoprotein E affects the central nervous system response to injury and the development of cerebral edema , 2002, Annals of neurology.

[32]  J. Olney,et al.  Apoptosis in the in Vivo Mammalian Forebrain , 2001, Neurobiology of Disease.

[33]  D. Diamond,et al.  Correlation between cognitive deficits and Aβ deposits in transgenic APP+PS1 mice , 2001, Neurobiology of Aging.

[34]  M. Vitek,et al.  Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice. , 2001, Journal of cell science.

[35]  J. Trojanowski,et al.  Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementia , 2001, Annals of neurology.

[36]  M. Hutton,et al.  Phenotypic correlations in FTDP-17 , 2001, Neurobiology of Aging.

[37]  J. Hardy,et al.  Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease , 2000, Nature.

[38]  Ralph A. Nixon,et al.  Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease , 2000, Nature.

[39]  J. Guralnik,et al.  Documented head injury in early adulthood and risk of Alzheimer’s disease and other dementias , 2000, Neurology.

[40]  E. Mandelkow,et al.  Structure, microtubule interactions, and paired helical filament aggregation by tau mutants of frontotemporal dementias. , 2000, Biochemistry.

[41]  L. Schmued,et al.  Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration , 2000, Brain Research.

[42]  Patrick R. Hof,et al.  Tau protein isoforms, phosphorylation and role in neurodegenerative disorders 1 1 These authors contributed equally to this work. , 2000, Brain Research Reviews.

[43]  R. Motter,et al.  Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease , 2000, Nature Medicine.

[44]  R. A. Crowther,et al.  Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein , 2000, Acta Neuropathologica.

[45]  J. Kuret,et al.  In vitro polymerization of tau protein monitored by laser light scattering: method and application to the study of FTDP-17 mutants. , 2000, Biochemistry.

[46]  C. DeCarli,et al.  Head injury and the risk of AD in the MIRAGE study , 2000, Neurology.

[47]  A. Fagan,et al.  Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Jacqueline N. Crawley,et al.  What's Wrong With My Mouse?: Behavioral Phenotyping of Transgenic and Knockout Mice , 2000 .

[49]  T. Révész,et al.  Neuronal cytoskeletal changes are an early consequence of repetitive head injury , 1999, Acta Neuropathologica.

[50]  R. Motter,et al.  Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse , 1999, Nature.

[51]  J. Mcculloch,et al.  Drug development for stroke: importance of protecting cerebral white matter. , 1999, European journal of pharmacology.

[52]  S. Lovestone,et al.  Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation , 1999, FEBS letters.

[53]  A. Delacourte,et al.  Neurofibrillary Degeneration in Progressive Supranuclear Palsy and Corticobasal Degeneration , 1999, Journal of neurochemistry.

[54]  John X. Morris,et al.  Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. , 1998, Science.

[55]  E. Mandelkow,et al.  Overexpression of Tau Protein Inhibits Kinesin-dependent Trafficking of Vesicles, Mitochondria, and Endoplasmic Reticulum: Implications for Alzheimer's Disease , 1998, The Journal of cell biology.

[56]  M. Goedert,et al.  Tau proteins with FTDP‐17 mutations have a reduced ability to promote microtubule assembly , 1998, FEBS letters.

[57]  D. Ingram,et al.  Stereological estimation of total microglia number in mouse hippocampus , 1998, Journal of Neuroscience Methods.

[58]  K. Nave,et al.  Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. , 1998, Science.

[59]  B. Hyman,et al.  APPSW Transgenic Mice Develop Age‐related Aβ Deposits and Neuropil Abnormalities, but no Neuronal Loss in CA1 , 1997, Journal of neuropathology and experimental neurology.

[60]  T. Kamei,et al.  Amyotrophic lateral sclerosis with numerous axonal spheroids in the corticospinal tract and massive degeneration of the cortex , 1997, Acta Neuropathologica.

[61]  S. Younkin,et al.  Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.

[62]  R. Terry The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis. , 1996, Journal of neuropathology and experimental neurology.

[63]  L. Mucke,et al.  Comparison of Neurodegenerative Pathology in Transgenic Mice Overexpressing V717F β-Amyloid Precursor Protein and Alzheimer’s Disease , 1996, The Journal of Neuroscience.

[64]  A. Faissner,et al.  Tau Binds to the Distal Axon Early in Development of Polarity in a Microtubule- and Microfilament-Dependent Manner , 1996, The Journal of Neuroscience.

[65]  I. Fischer,et al.  Tau Is Enriched on Dynamic Microtubules in the Distal Region of Growing Axons , 1996, The Journal of Neuroscience.

[66]  J. Geddes,et al.  Neurofibrillary tangles, but not Alzheimer‐type pathology, in a young boxer , 1996, Neuropathology and applied neurobiology.

[67]  J. Olney,et al.  MK-801 neurotoxicity in male mice: histologic effects and chronic impairment in spatial learning , 1996, Brain Research.

[68]  A. Marmarou,et al.  A new model of diffuse brain injury in rats. Part I: Pathophysiology and biomechanics. , 1994, Journal of neurosurgery.

[69]  T. Deerinck,et al.  Re‐Evaluation of the Structural Organization of Neuritic Plaques in Alzheimer's Disease , 1993 .

[70]  Roland S. G. Jones Entorhinal-hippocampal connections: a speculative view of their function , 1993, Trends in Neurosciences.

[71]  H. Gundersen,et al.  Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator , 1991, The Anatomical record.

[72]  K. Kosik,et al.  Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons , 1990, Nature.

[73]  A. Frankfurter,et al.  The distribution of tau in the mammalian central nervous system , 1985, The Journal of cell biology.

[74]  L M Schuman,et al.  Head injury as a risk factor for Alzheimer's disease , 1985, Neurology.

[75]  W E Wilkinson,et al.  Alzheimer's disease: A study of epidemiological aspects , 1984, Annals of neurology.

[76]  M. Kirschner,et al.  Studies on the expression of the microtubule-associated protein, tau, during mouse brain development, with newly isolated complementary DNA probes , 1984, The Journal of cell biology.

[77]  M. Kirschner,et al.  A protein factor essential for microtubule assembly. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[78]  W. R. Ingram,et al.  An improved cupric-silver method for impregnation of axonal and terminal degeneration. , 1971, Brain research.

[79]  H. Qing,et al.  Valproic acid inhibits Aβ production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models , 2008, The Journal of Experimental Medicine.

[80]  M. Asunción Morán,et al.  Ultrastructural localization of intraneuronal Abeta-peptide in Alzheimer disease brains. , 2007, Journal of Alzheimer's disease : JAD.

[81]  R. Berry,et al.  Conformational changes and truncation of tau protein during tangle evolution in Alzheimer's disease. , 2003, Journal of Alzheimer's disease : JAD.

[82]  Dennis W. Dickson,et al.  Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process , 2002, Acta Neuropathologica.

[83]  B. Jordan,et al.  Chronic Traumatic Brain Injury Associated with Boxing , 2000, Seminars in neurology.

[84]  M. Goedert,et al.  The tauopathies: toward an experimental animal model. , 1999, The American journal of pathology.

[85]  B. Pike,et al.  The rotarod test: an evaluation of its effectiveness in assessing motor deficits following traumatic brain injury. , 1994, Journal of neurotrauma.